Norgine

N/A

Clinical Trials (1)

NCT02468726Performance of NER1008 Enema Compared With Fleet® Enema in Bowel Cleansing

N/A

No intervention

Routine Colonoscopy

N/A

Clinical Trials (1)

NCT01626196Evaluation of the Main Determinants of Patient Acceptability of the Bowel Cleansing Procedure, and of Success of Bowel Cleansing and Caecal Intubation

N/A

Comparative Study of Colon Capsule and Virtual Colonoscopy (VICOCA)

Colonic Polyps

N/A

Clinical Trials (1)

NCT02081742Comparative Study of Colon Capsule and Virtual Colonoscopy (VICOCA)

N/A

Endocuff group

Adenoma Detection Rate

N/A

Clinical Trials (1)

NCT03442738A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®)

N/A

NRL972

Cirrhosis

Phase 1

Clinical Trials (1)

NCT01164332Sensitivity of Alternative NRL972 Detection Methods in Healthy Subjects

Phase 1

TF037

Digestive System Disorders

Phase 1

Clinical Trials (1)

NCT01715272A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compared With Fleet Enema

Phase 1

Ulimorelin

Phase 1

Clinical Trials (1)

NCT01405599Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects

Phase 1

Perianal NRL001 Gel 3 strengths

Faecal Incontinence

Phase 1

Clinical Trials (1)

NCT06593743The Safety and Dose Response to Single Anal Doses of NRL001

Phase 1

NRL001

Phase 1

Clinical Trials (1)

NCT01175941Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence

Phase 1

NRL001

Phase 1

Clinical Trials (1)

NCT00893607Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum

Phase 1

NRL972

Phase 1

Clinical Trials (1)

NCT00896597Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis

Phase 1

NRL972

Pharmacokinetics

Phase 1

Clinical Trials (1)

NCT00856752Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine

Phase 1

NRL001

Phase 1

Clinical Trials (1)

NCT01099670Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Suppository for 14 Days

Phase 1

NRL001 cream 0.5%w/w

Faecal Incontinence

Phase 1

Clinical Trials (1)

NCT06593730Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days

Phase 1

Placebo control

Digestive System Disorders

Phase 1

Clinical Trials (1)

NCT01406925Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers

Phase 1

Midazolam

Phase 1

Clinical Trials (1)

NCT01405612Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers

Phase 1

PLENVU powder for oral solution

Pharmacokinetic

Phase 1

Clinical Trials (1)

NCT03437265A Pharmacokinetic Study of PLENVU® in Healthy Subjects

Phase 1

NER1006

Phase 1

Clinical Trials (1)

NCT01834742Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects

Phase 1

NRL972

Phase 1

Clinical Trials (1)

NCT00856713Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers

Phase 1

PEG 3350 plus electrolytes

Chronic Constipation

Phase 1

Clinical Trials (1)

NCT00868985Effects of Oral PEG 3350 on Electrolyte Balance

Phase 1

NRL001

Incontinence

Phase 1

Clinical Trials (1)

NCT00850590Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights

Phase 1

NRL972

Phase 1

Clinical Trials (1)

NCT00857480Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin

Phase 1

TZP-101

Postoperative Ileus

Phase 1

Clinical Trials (1)

NCT01668199A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101

Phase 1

Klean-Prep®

Gastric Emptying

Phase 1

Clinical Trials (1)

NCT00896246Scintigraphic Assessment Following Klean-Prep® or Moviprep®

Phase 1

NRL001

Phase 1

Clinical Trials (1)

NCT00857467Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001.

Phase 1

NRL001

Phase 1

Clinical Trials (1)

NCT01099683Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects

Phase 1

Zegerid

Acid Reflux

Phase 1

Clinical Trials (1)

NCT01710995A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

Phase 1

NRL972

Phase 1/2

Clinical Trials (1)

NCT00856869Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Phase 1/2

Polyethylene glycol 3350 NA bicarbonate NaCl KCl

Feces, Impacted

Phase 2

Clinical Trials (1)

NCT00403858Movicol in Childhood Constipation (ProMotion Study)

Phase 2

macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

Phase 2

Clinical Trials (1)

NCT00321230Clinical Evaluation of a New Reduced Volume Bowel Preparation

Phase 2

Polyethylene glycol 3350 NA bicarbonate NaCl KCl

Chronic Constipation

Phase 2

Clinical Trials (1)

NCT00404040Movicol in Childhood Constipation (ProMotion Study)

Phase 2

NRL972

Hepatitis, Viral, Human

Phase 2

Clinical Trials (1)

NCT00915057Effect of Chronic Viral Hepatitis on the Pharmacokinetics of NRL972.

Phase 2

NER1006

Colon Cancer

Phase 2

Clinical Trials (1)

NCT01714466Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy

Phase 2

macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

Phase 2

Clinical Trials (1)

NCT00312481MOVIPREP® Versus PICOLAX® Pilot Study

Phase 2

NRL994

Non-Alcoholic Fatty Liver Disease

Phase 2

Clinical Trials (1)

NCT06597903A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution

Phase 2

NRL972

Phase 2

Clinical Trials (1)

NCT00794716PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD)

Phase 2

NRL0706

Colon Cancer

Phase 2

Clinical Trials (1)

NCT01251237Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies

Phase 2

1R, 2S-methoxamine hydrochloride

Faecal Incontinence

Phase 2

Clinical Trials (1)

NCT01656720A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period

Phase 2

MOVIPREP

Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.

Phase 3

PLENVU®

Bowel Cleansing Prior to Clinical Procedures

Phase 3

Polyethylene glycol 3350 Na bicarbonate NaCl KCl

Chronic Constipation

Phase 3

Clinical Trials (1)

NCT00403897An Open Single Centre Study To Assess Treatment of Chronic Constipation in Children

Phase 3

Macrogol 3350 Na sulphate NaCl KCl Ascorbic Acid Na Ascorbate

Phase 3

Clinical Trials (1)

NCT00427089Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening

Phase 3

NER1006, 2-Day Split-Dosing